Advertisement

Pathophysiologie, Klinik und Prognose des Hochdruckherzens

  • Ingomar-Werner Franz
Chapter
  • 9 Downloads

Zusammenfassung

Im Verlauf der arteriellen Hypertonie kommt es zu typischen funktionellen und strukturellen Veränderungen des linken Ventrikels und der Koronargefäße [15, 37, 71, 74, 139, 141, 215, 223, 225], die unabhängig voneinander zu einer gestörten Pumpfunktion zunächst in Ruhe, dann bei Belastung und im Spätstadium auch zu einem Pumpversagen des Herzens führen können (Abb. 46).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literaturverzeichnis

  1. 1.
    Abi Samra F, Fouad EM, Tarazi RC (1983) Determinants of left ventricular hypertrophy and function in hypertensive patients. Am J Med 75 (Suppl):26PubMedCrossRefGoogle Scholar
  2. 2.
    Alli C, Avanzini F, Di Tullio M, Ariotti G, Salmoirago E, Taioli E, Radice M (1990) Left ventricular diastolic function in normotensive adolescents with different genetic risk of hypertension. Clin Cardiol 12:115CrossRefGoogle Scholar
  3. 3.
    Amer MS, Doba N, Reis DJ (1975) Changes in cyclic nucleotide metabolism in aorta and heart of neurogenically hypertensive rats: possible trigger mechanism of hypertension. Proc Natl Acad Sci, USA 72:2135PubMedCrossRefGoogle Scholar
  4. 4.
    Amodeo C, Kobrin J, Ventura HO, Messerli FH, Frohlich ED (1986) Immediate and short-term hemodynamic effect of diltiazem in patients with hypertension. Circulation 73:108PubMedCrossRefGoogle Scholar
  5. 5.
    Anderson KP (1984) Sudden death, hypertension and hypertrophy. J Cardiovasc Pharmacol 6:S498PubMedCrossRefGoogle Scholar
  6. 6.
    Appleton CP, Hatle LK, Popp RL (1988) Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and doppler echocardiographic study. J Amer Coll Cardiol 12:426CrossRefGoogle Scholar
  7. 7.
    Asmar RG, Pannier B, Santoni JPh, Laurent St, London GM, Levy BI, Safar ME (1988) Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. Circulation 78:941PubMedCrossRefGoogle Scholar
  8. 8.
    Bachmann K, Zerzawy R, Riess PJ, Zölch KA (1970) Blutdrucktelemetrie — kontinuierliche, direkte Blutdruckmessung im Alltag und beim Sport. Dtsch Med Wochenschr 95:741PubMedCrossRefGoogle Scholar
  9. 9.
    Baumgart P, Reinbach R, Akbulut T, Walger P, Thiel M, v Eiff M, Gerke M, Rahn KH (1990) Sprechstundenblutdruck, Heimblutdruck, Ergometer-Blutdruck und 24-Stunden-Blutdruck. Dtsch Med Wochenschr 115:643PubMedCrossRefGoogle Scholar
  10. 10.
    Blake J, Devereux R, Henold E, Jason M, Fisher J, Borer J, Laragh JH (1988) Relation of concentric left ventricular hypertrophy and extracardiac target organ damage to supranormal left ventricular performance in established essential hypertension. Am J Cardiol 62:246PubMedCrossRefGoogle Scholar
  11. 11.
    Blake J, Devereux RB, Borer JS, Szulc M, Pappas TW, Laragh JH (1990) Relation of obesity, high sodium intake and eccentric left ventricular hypertrophy of left ventricular exercise dysfunction in essential hypertension. Am J Med 88:477PubMedCrossRefGoogle Scholar
  12. 12.
    Bobik A, Korner P (1981) Cardiac beta adrenoceptors and adenylate cyclase in normotensive and renal hypertensive rabbits during changes in autonomic activity. Clin Exp Hypertens 3:257PubMedCrossRefGoogle Scholar
  13. 13.
    Boden WE, Kleiger RE, Schlechtmann K, Capone R, Schwartz DJ, Gibson R (1988) Clinical significance and importance of left ventricular hypertrophy in N-Q-Wave acute myocardial infarction. Am J Cardiol 62:1000PubMedCrossRefGoogle Scholar
  14. 14.
    Boudoulas H, Mantzouratos D, Sohn YH, Weissler AM (1986) Left ventricular mass and systolic performance in chronic systemic hypertension. Am J Cardiol 57:232PubMedCrossRefGoogle Scholar
  15. 15.
    Brush JE, Cannon RO, Schenke WH, Bonow RO, Leon M, Maron BJ, Epstein S (1988) Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. New Engl J Med 319:302CrossRefGoogle Scholar
  16. 16.
    Bryg RJ, Williams GA, Labowitz AJ (1987) Effect of aging on left ventricular diastolic filling in normal subjects. Amer J Cardiol 59:971PubMedCrossRefGoogle Scholar
  17. 17.
    Campasso JM, Strobeck JE, Sonnenblick EH (1981) Myocardial mechanical alterations during gradual onset long-term hypertension in rats. Am J Physiol 241:H435, 379Google Scholar
  18. 18.
    Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker Oxprenolol (1985): the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group. J Hypertens 3:379Google Scholar
  19. 19.
    Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, Laragh JH (1986) Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 105:173PubMedGoogle Scholar
  20. 20.
    Caspari PG, Newcomb M, Gibson K, Harris P (1979) Collagen in the normal and hypertrophied human ventricle. Cardiovas Res 11:554CrossRefGoogle Scholar
  21. 21.
    Cerasola G, Cottorie S, Nardi E, Novo S, Coutorno A (1989) Reversal of cardiac hypertrophy and left ventricular performance in hypertension. Fourth European Meeting on Hypertension, Milan, Abstract 139Google Scholar
  22. 22.
    Cifkova R, Niederle P, Romanowska C, Skibova J, Friedl P, Skalicka H, Widimsky J (1987) The heart and vessal hypertrophy in hypertension; possibilities of its regression. Third European Meeting on Hypertension, Milan, Abstract 97Google Scholar
  23. 23.
    Cohen A, Hagan AD, Watkins J, Mitas J, Schwartzman M, Mazzoleni A, Cohen IM, Warren SE, Vieweg WVR (1981) Clinical correlates in hypertensive patients with left ventricular hypertrophy diagnosed with echocardiography. Am J Cardiol 47:355Google Scholar
  24. 24.
    Corea L, Bentivoglio M, Verdecchia P, Provvidenza M, Motolese M (1984) Regression of left ventricular hypertrophy during metoprolol treatment. Int J Clin Pharmacol 22:365Google Scholar
  25. 25.
    Cruickshank JM (1988) Coronary flow reserve and the J-curve relation between diastolic blood pressure and myocardial infarction. Br Med J 297:1227CrossRefGoogle Scholar
  26. 26.
    Cruickshank JM, Thorp JM, Zacharias FJ (1987) Benefits and potential harm of lowering high blood pressure. Lancet 1:581PubMedCrossRefGoogle Scholar
  27. 27.
    Cuocolo A, Sax FL, Brush JE, Maron BJ, Bacharach S, Bonow RO (1990) Left ventricular hypertrophy and impaired diastolic filling in essential hypertension. Circulation 81:978PubMedCrossRefGoogle Scholar
  28. 28.
    Culpepper WS, Scott PC, Messerli FH (1983) Cardiac status in juvenile borderline hypertension. Am Intern Med 98:1Google Scholar
  29. 29.
    Curtius JM, Gäbel K, Welslan R, Hilger HH (1990) Reproduzierbarkeit doppler-echokardiographischer Parameter der linksventrikulären diastolischen Funktion. Z Kardiol 79:69Google Scholar
  30. 30.
    Dellsberger KC (in print) The effect of coronary artery occlusion on animals with hypertension and left ventricular hypertrophy. J Cardiovasc PharmacolGoogle Scholar
  31. 31.
    De Maria AN, Neumann A, Lee G, Fowler W, Mason D (1978) Alterations in ventricular mass and performance induced by exercise training in man evaluated by echocardiography. Circulation 57:237Google Scholar
  32. 32.
    Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613PubMedGoogle Scholar
  33. 33.
    Devereux RB, Savage DD, Drayer JIM, Laragh JH (1982) Left ventricular hypertrophy and function in high normal, and low-renin forms of essential hypertension. Hypertension 4:524PubMedGoogle Scholar
  34. 34.
    Devereux RB, Pickering TG, Harshfield GA (1983) Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation 68:470PubMedCrossRefGoogle Scholar
  35. 35.
    Devereux RB, Lutas EM, Casale PN, Kligfield, Eisenberg RR, Hammond JW, Miller DH, Reis G, Aldermann MH (1984) Standardization of m-mode echocardiographic left ventricular anatomic measurements. Am Col Cardiol 4:1222CrossRefGoogle Scholar
  36. 36.
    Devereux RB, Alonso DR, Untas EM, Gottlieb GJ, Campo E, Sachs J, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 57:450PubMedCrossRefGoogle Scholar
  37. 37.
    Devereux RB (1989) Echocardiographic insights into the pathophysiology and prognostic significance of hypertensive cardiac hypertrophy. Am J Hyp 2:186Google Scholar
  38. 38.
    Dickhut H-H, Jakob E, Steiger J, Keul J (1987) Echokardiographische Befunde beim Sportherz. In: Rost R, Webering F (Hrsg) Kardiologie im Sport. Deutscher Ärzteverlag, Köln, S 132Google Scholar
  39. 39.
    Dimitriou R, de Gaudemaris R, Debru JL, Mallion JM (1985) Wirkung von Betaxolol auf die linksventrikuläre Hypertrophie bei Hypertonikern: echokardiographische Studie. JAMA 4:10 (Dtsch Ausgabe, Sonderheft)Google Scholar
  40. 40.
    Dimitriu M, Klempt HW, Kostic N, Faber L (1989) Die diastolische linksventrikuläre Funktion bei Gesunden und Patienten mit koronarer Herzerkrankung. Eine dopplerechokardiographische Untersuchung unter Ergometerbelastung. Herz-Kreisl: 5Google Scholar
  41. 41.
    Douglas PS, O’Toole MC, Hiller DB, Hackney K, Reichek N (1988) Electrocardiographic diagnosis of exercise-induced left ventricular hypertrophy. Am Heart J 116:784PubMedCrossRefGoogle Scholar
  42. 42.
    Drayer JIM, Gardin JM, Weber MA, Aronow WS (1982) Increases and decreases in ventricular septal thickness during diuretic therapy. Clin Pharmacol Ther 32:283PubMedCrossRefGoogle Scholar
  43. 43.
    Drayer JIM, Gardin JM, Weber MA, Aronow WS (1983) Cardiac muscle mass during vasodilatation therapy of hypertension. Clin Pharmacol Ther 33:727PubMedCrossRefGoogle Scholar
  44. 44.
    Drayer JI, Weber MA, DeYoung JL (1983) BP as determinant of cardiac left ventricular muscle mass. Arch Intern Med 143:90PubMedCrossRefGoogle Scholar
  45. 45.
    Drexler H, Zeiher AM, Holtz J, Meinertz T, Just H (1990) Einfluß des atrialen natriuretischen Faktors auf den koronaren Gefaßtonus. Z Kardiol 79:621PubMedGoogle Scholar
  46. 46.
    Dunn FG, Chandraratna P, de Carvalho JGR, Basta LL, Frohlich ED (1977) Pathophysiologic assessment of hypertension heart disease with echocardiography. Am J Cardiol 39:789PubMedCrossRefGoogle Scholar
  47. 47.
    Dunn RF, Wolff L, Wagner S, Botvinick EH (1981) The inconsistent pattern of thallium defects. A clue to the false positive perfusion szintigramm. Am J Cardiol 48:224PubMedCrossRefGoogle Scholar
  48. 48.
    Easthan LL, Doty DB, Hiratzka LF, Wright CB, Marcus ML (1981) Volume-overload left ventricular hypertrophy impairs coronary reserve in humans. Circulation 64 (Suppl IV):IV 26 (Abstract)Google Scholar
  49. 49.
    Ehsani AA, Hagberg JM, Hickson RC (1978) Rapid changes in left ventricular dimensions and mass in response to physical conditioning and deconditioning. Am J Cardiol 42:52PubMedCrossRefGoogle Scholar
  50. 50.
    Eisenlohr H, Klepzig M, Schmiebusch H, Strauer BE (1989) Hypertensive Mikroangiopathie — Therapieinduzierte Regression der Mediahypertrophie in koronaren Widerstandsgefäßen. Cor Vas 3:72Google Scholar
  51. 51.
    Erbel R, Zschiedrich H, Drexler M, Henrichs K, Wittlich N, Braun C, Meyer J (1988) Wertigkeit der Echokardiographie bei der Beurteilung der Linksherzhypertrophie. Münch Med Wochenschr 130:26Google Scholar
  52. 52.
    Fast J, Jacobs S, van Dam J, Keulen P, Hopman J, Daniels O, Lenders J, Thien Th (1989) Abnormal left ventricular filling: an early finding in mild systemic hypertension. Fourth European Meeting on Hypertension, Milan, Abstract 248Google Scholar
  53. 53.
    Feldstein CA, Olivieri AO, Sabaris RP (1988) Comparison between the effect of Urapidil and methyldopa on left ventricular hypertrophy and haemodynamics in humans. Drugs 35 (Suppl 6):90PubMedCrossRefGoogle Scholar
  54. 54.
    Floras JS (1988) Antihypertensive treatment, myocardial infarction, and nocturnal myocardial ischaemia. Lancet 1:994CrossRefGoogle Scholar
  55. 55.
    Fouad FM, Nakashima Y, Tarazi RC, Salcedo EE (1982) Reversal of left ventricular hypertrophy in hypertensive patients treated with methyldopa. Am J Cardiol 49:795PubMedCrossRefGoogle Scholar
  56. 56.
    Fouad-Tarazi FM (1990) Radionuclide ventriculography in the assessment of diastolic function in hypertension. Herz 15:393PubMedGoogle Scholar
  57. 57.
    Francis CK, Ciernan M, Berger HJ, Davies RA, Giles RW, Black HR, Vita N, Zito RA, Zaret BL (1983) Left ventricular systolic performance during upright bicycle exercise in patients with essential hypertension. Am J Med (Suppl):40Google Scholar
  58. 58.
    Franz I-W (1980) Differential antihypertensive effect of acebutolol and the fixed combination hydrochlorothiazide/amiloride hydrochloride on elevated exercise blood pressure in hypertensive patients. Am J Cardiol 46:301PubMedCrossRefGoogle Scholar
  59. 59.
    Franz I-W, Mellerowicz H (1980) Vergleichende ergometrische Untersuchungen über den Tension-Time-Index und die körperliche Leistungsbreite bei Patienten mit grenzwertiger und stabiler Hypertonie und Normalpersonen. Z Kardiol 69:587PubMedGoogle Scholar
  60. 60.
    Franz I-W (Hrsg) (1981) Belastungsblutdruck bei Hochdruckkranken. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  61. 61.
    Franz I-W (1982) Ergometrie bei Hochdruckkranken. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  62. 62.
    Franz I-W (1983) The effects of prazosin and acebutolol and their combination on blood pressure and pressure rate product during ergometric work in hypertensive patients. Z Kardiol 72:21Google Scholar
  63. 63.
    Franz I-W (1984) Isometrische und dynamische Belastung als Kriterium für die Therapiebeurteilung. In: Holzgreve H, Rost R (Hrsg) Aktuelles und Kontroverses aus der Hochdruckforschung. MMW-Medizin Verlag, München, S 107Google Scholar
  64. 64.
    Franz I-W (1986) β-Rezeptorenblocker in der Hochdrucktherapie. Hämodynamische und metabolische Aspekte und Kombinierbarkeit mit anderen Antihypertensiva. Springer, Berlin Heidelberg New YorkGoogle Scholar
  65. 65.
    Franz I-W., Wiewel D, Behr U, Ketelhut R (1986) Rückbildung der Myokard-hypertrophie Hochdruckkranker unter chronischer β-Rezeptorenblockade. Dtsch Med Wochenschr 111:530PubMedCrossRefGoogle Scholar
  66. 66.
    Franz I-W, Behr U, Ketelhut R (1987) Resting and exercise blood pressure with atenolol, enalapril and a low-dose combination. Hypertension 5 (Suppl 3):37Google Scholar
  67. 67.
    Franz I-W, Tönnesmann U, Behr U, Ketelhut R (1987) Longterm effect of antihypertensive therapy on left ventricular hypertrophy. Hypertension 5 (Suppl 5):415Google Scholar
  68. 68.
    Franz I-W (1988) Ergometrische Diagnostik bei Koronar- und Hochdruckpatienten. Med Welt 39:230Google Scholar
  69. 69.
    Franz I-W (1989) Soll die Belastungshypertonie behandelt werden? „Pro“ Mitt Klin Nephrologie XVIII:51Google Scholar
  70. 70.
    Franz I-W, Tönnesmann U, Behr U, Ketelhut R (1989) Regression der Linksherzhypertrophie Hochdruckkranker durch antihypertensive Therapie. Kardiol 78 (Suppl 5):43Google Scholar
  71. 71.
    Franz I-W, Tönnesmann U, Erb D (1989) Die in Ruhe echokardiographisch unauffällige linksventrikuläre Funktion ist bei Hypertonikern während Belastung gestört trotz unauffälligem Koronarangiogramm. Hochdruck 9:66Google Scholar
  72. 72.
    Franz I-W, Tönnesmann U, Behr U, Ketelhut R (1990) Rückbildung der Linksherzhypertrophie bei Hochdruckkranken durch antihypertensive Langzeittherapie. Dtsch Med Wochenschr 115:603PubMedCrossRefGoogle Scholar
  73. 73.
    Franz I-W (1991) Hochdruckherz und Sport. In: Schulte KH, Gotzen R (Hrsg) Kardiales Risiko und Sport. Steinkopff, Darmstadt, S. 37CrossRefGoogle Scholar
  74. 74.
    Franz I-W, Ketelhut R, Behr U, Tönnesmann U (1991) Long-term studies on regression of left ventricular hypertrophy. J Cardiovasc Pharmacol 17 (Suppl 2):87CrossRefGoogle Scholar
  75. 75.
    Franz I-W, Tönnesmann U, Erb D, Ketelhut R (1991) Impaired left ventricular function during exercise in hypertensives with normal coronary arteriograms. J Cardiovasc Pharmacol 17: (Suppl 2):133CrossRefGoogle Scholar
  76. 76.
    Frenzel H, Schwartzkopff B, Flasshove M, Betz P, Motz W, Hort W (1990) Postmortale und bioptische Untersuchungen an den kleinen Arterien des Herzens bei essentieller Hypertonie. Z Kardiol 79 (Suppl 1):80Google Scholar
  77. 77.
    Friedmann BJ, Drinkovic N, Miles H, Shih WJ, Mazzoleni A, De Maria AN (1986) Assessment of left ventricular diastolic function. Comparison of Doppler and gated blood pool scintigraphy. J Am Coll Cardiol 8:1348CrossRefGoogle Scholar
  78. 78.
    Frohlich ED, Tarazi RC (1979) Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? Am J Cardiol 44:459CrossRefGoogle Scholar
  79. 79.
    Frohlich ED (1980) Left ventricular hypertrophy as a risk factor. Cardiol Clin 4:137Google Scholar
  80. 80.
    Gaglione A, Hess OM, Corin W, Ritter M, Grimm J, Krayenbuehl HP (1987) Is there coronary vasoconstriction after intracoronary beta-adrenergic blockade in patients with coronary artery disease. J Am Coll Cardiol 70:299CrossRefGoogle Scholar
  81. 81.
    Garavaglia G, Messerli F, Nunez B, Schmieder R, Frohlich ED (1988) Immediate and short-term cardiovascular effects of a new converting enzym inhibitor in essential hypertension. Am J Cardiol 62:912PubMedCrossRefGoogle Scholar
  82. 82.
    Gilbert C, Nutter D, Feiner J, Perkins J, Heymsfield S, Schlant R (1977) Echocar-diographic study of cardiac dimensions and function in the endurance-trained athlet. Am J Cardiol 40:528PubMedCrossRefGoogle Scholar
  83. 83.
    Gosse P, Roudant R, Reynand P, Ullien E, Dallochio M (1989) Relationship between left ventricular mass and noninvasive monitoring of blood pressure. Am J Hypertens 2:631PubMedGoogle Scholar
  84. 84.
    Gosse P, Roudant R, Herrero G, Dallocchio M (1989) Left ventricular mass and function and ambulatory blood pressure in essential hypertension. Effects of bisoprolol versus enalapril. Fourth European Meeting on Hypertension, Milan, Abstract 306Google Scholar
  85. 85.
    Gosse P, Durandet P, Roudant R, Broustet J-P., Dallocchio M (1989) Prognostic value of blood pressure response during exercise in hypertensive patients. Fourth European Meeting on Hypertension, Milan, Abstract 307Google Scholar
  86. 86.
    Gottdiener JS, Brown J, Zoltick J, Fletcher RD (1990) Left ventricular hypertrophy in men with normal blood pressure: relation to exaggerated blood pressure response to exercise. Am Intern Med 3:161Google Scholar
  87. 87.
    Granger CB, Karimeddini MK, Smith VE, Shapiro HR, Katz AM, Riba AL (1987) Rapid ventricular filling in left ventricular hypertrophy. I. Physiologic hypertrophy. J Am Coll Cardiol 5:862CrossRefGoogle Scholar
  88. 88.
    Gros F (1971) The renin angiotensin system and hypertension. Ann Intern Med 75:777Google Scholar
  89. 89.
    Grossmann W, Jones D, Mc Laurin LP (1975) Wallstress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56:56CrossRefGoogle Scholar
  90. 90.
    Grossmann E, Oren S, Garavaglia G, Messerli F, Frohlich ED (1988) Systemic and regional hemodynamic and humoral effects of nitrendipine in essential hypertension. Circulation 78:1394CrossRefGoogle Scholar
  91. 91.
    Haegerty AM, Bund SJ, Aalkjaer C (1988) Effects of drug treatment on human resistance arteriole morphology in essential hypertension: direct evidence for structural remodelling of resistance vessel. Lancet 11:1209CrossRefGoogle Scholar
  92. 92.
    Hammond IW, Devereux RB, Aldermann MH, Lutas BM, Spitzer MD, Crowley JS, Laragh JH (1986) The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. Am Coll Cardiol 7:639CrossRefGoogle Scholar
  93. 93.
    Harrison DG, Florentine MS, Brooks LA, Cooper SM, Marcus ML (1988) The effect of hypertension and left ventricular hypertrophy on the lower range of coronary autoregulation. Circulation 77:1108PubMedCrossRefGoogle Scholar
  94. 94.
    Haugland H, Pedersen OM, Fölling M (1986) Changes in left ventricular septal thickness in systemic hypertension during treatment with methyldopa and prazosin. Am J Cardiol 58:565PubMedCrossRefGoogle Scholar
  95. 95.
    HDFP (1979) Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 242:2562CrossRefGoogle Scholar
  96. 96.
    Hess OM, Ritter M, Schneider MS, Grimm J, Turina M, Krayenbuehl HP (1984) Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement. Circulation 69:855PubMedCrossRefGoogle Scholar
  97. 97.
    Ibrahim MM, Madkour MA, Mossallam R (1981) Effect of Beta blockade therapy on hypertensive cardiac hypertrophy. Am J Cardiol 47:469aCrossRefGoogle Scholar
  98. 98.
    Ibrahim MM, Madkour MA, Mossalem R (1981) Factors influencing cardiac hypertrophy in hypertensive patients. Clin Sci 61 (Suppl 7): 105Google Scholar
  99. 99.
    Inouye I, Massie BM, Loje D (1984) Abnormal left ventricular filling: an early finding in mild-to-moderate systemic hypertension. Am J Cardiol 53:120PubMedCrossRefGoogle Scholar
  100. 100.
    Jacob R, Brenner B, Ebrecht G, Holubarsch Ch, Medugorac I (1980) Elastic and contractile properties of the myocardium in experimental cardiac hypertrophy of the rat. Methodological and pathophysiological considerations. Basic Res Cardiol 75:253PubMedCrossRefGoogle Scholar
  101. 101.
    Jalil JE, Janicki JS, Shroff SG, Prick R, Weber KT (1989) Captopril treatment and myocardial fibrosis and stiffness in renovascular hypertensive rats. J Am Coll Cardiol 13:82A (Abstract)Google Scholar
  102. 102.
    Jennings G, Korner P, Laufer E, Meredith J, Part T, Dewar E (in print) Non-pharmacological control of blood pressure and cardiovascular hypertrophy. J Cardiovasc PharmacolGoogle Scholar
  103. 103.
    Jones E, Morgan TO, Califiore PI, Johns J (1990) Prevalence of left ventricular hypertrophy in elderly patients with well controlled hypertension. Clin Exp Pharmacol Physiol 17:207PubMedCrossRefGoogle Scholar
  104. 104.
    Julien J, Dufloux M-A, Prasquier R, Chatellier G, Menard D, Plouin P-F, Menard J, Corvol P (1990) Effects of Captopril and minoxidil on left ventricular hypertrophy in resistant hypertensive patients: A 6 months double-blind comparison. J Am Coll Cardiol 16:137PubMedCrossRefGoogle Scholar
  105. 105.
    Kaesser U, Messerli FH, Cosen C, Frohlich ED (1989) Left ventricular conduction delay in hypertensive heart disease. Circulation 80 (Suppl II):596Google Scholar
  106. 106.
    Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M (1972) Role of blood pressure in the development of congestive heart failure. New Engl J Med 287:781PubMedCrossRefGoogle Scholar
  107. 107.
    Kannel WB, Doyle JT, McNamara PM, Quinkenton P, Gordon T (1975) Precursor of sudden coronary death: factors related to the incidence of sudden death. Circulation 51:606PubMedGoogle Scholar
  108. 108.
    Kannel WB (1983) Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med 75 (Suppl 3A):4PubMedCrossRefGoogle Scholar
  109. 109.
    Kannel WB, Abott RD (1986) A prognostic comparison of asymptomatic left ventricular hypertrophy and unrecognized myocardial infarction. The Framing-ham Study. Am Heart J 111:391PubMedCrossRefGoogle Scholar
  110. 110.
    Kannel WB, Levy D, Cupples LA (1987) Left ventricular hypertrophy and risk of cardiac failure: Insights from the Framingham Study. J Cardiovasc Pharmacol 10 (Suppl 6): 135Google Scholar
  111. 111.
    Kannel WB, d’Agostino RB, Levy D, Belanger HH (1988) Prognostic significance of regression of left ventricular hypertrophy. Circulation 78 (Suppl 2): 89Google Scholar
  112. 112.
    Kannel WB, Cupples LA, d’Agostino RB, Stokes J (1988) Hypertension, antihypertensive treatment and sudden coronary deaths. The Framingham Study. Hypertension 11 (Suppl II):45Google Scholar
  113. 113.
    Kaul M, Mohan JC, Bhatia M (1984) Effects of labetalol on left ventricular mass and function in hypertension. An assessment by serial echocardiography. Int J Cardiol 5:461PubMedCrossRefGoogle Scholar
  114. 114.
    Keeley FW, Elmoselhi A, Leenen FH (in print) Effects of antihypertensive drug classes on regression of connective tissue components of hypertension. J Cardiovasc PharmacolGoogle Scholar
  115. 115.
    Keul J, Lehmann M, Dickhut H-H (1989) Hypertonie, Herz und körperliche Aktivität. Z Kardiol 78 (Suppl 7):199PubMedGoogle Scholar
  116. 116.
    Klaus D, Lederle RM, Saul F (1989) Regression der hypertensiven Linksherzhypertrophie unter einjähriger Kombinationsbehandlung mit Verapamil und Hy-drochlorothiazid/Triamteren. Herz/Kreisl 21:222Google Scholar
  117. 117.
    Klepzig M, Strauer B (1987) Coronary hemodynamics of hypertensive heart disease. J Cardiovasc Pharmacol 10:65Google Scholar
  118. 118.
    Klocke FJ (1987) Measurements of coronary flow reserve: defining pathophysiology versus making decisions about patient care. Circulation 76:1183PubMedCrossRefGoogle Scholar
  119. 119.
    Kobrin I, Jesoko S, Pegram BC, Frohlich ED (1984) Reduced cardiac mass by nitrendipine is dissociated from systemic or regional haemodynamic changes. Cardiovasc Res 18:158PubMedCrossRefGoogle Scholar
  120. 120.
    Köhler E (1990) Möglichkeiten und Grenzen der Echokardiographie. Z Kardiol 79:461PubMedGoogle Scholar
  121. 121.
    Köhler E, Völz G, Haertner K, Horstkolte D, Körfer R, Loogen F (1981) Echokardiographische Verlaufsbeobachtungen der linksventrikulären Größe und Funktion bei Patienten vor und nach prothetischem Aortenklappenersatz. Z Kardiol 70:660PubMedGoogle Scholar
  122. 122.
    Komsuoglu B, Özgür O, Duman EL, Komsuoglu SS (1989) The effect of chronic antihypertensive therapy on the index of left ventricular mass in patients with essential hypertension. Int J Cardiol 22:75PubMedCrossRefGoogle Scholar
  123. 123.
    Koyanagi S, Eastham C, Marcus ML (1988) Effects of chronic hypertension and left ventricular hypertrophy on the incidence of sudden cardiac death after coronary artery occlusion in conscious dogs. Circulation 65:517Google Scholar
  124. 124.
    Krayenbuehl HP, Hess OM, Schneider J, Turma M (1988) Regression der Myo-kardhypertrophie bei Aortenvitien nach Aortenklappenersatz. Schweiz Med Wo-chenschr 118:517Google Scholar
  125. 125.
    Krönig B (1976) Blutdruckvariabilität bei Hochdruckkranken. Hüthig HeidelbergGoogle Scholar
  126. 126.
    Kücherer H, Ruffmann K, Schaefer E, Kübier W (1988) Nichtinvasive Bestimmung linksventrikulärer diastolischer Füllungsparameter mittels Dopplerechokardiographie. Klinische Anwendung bei Patienten mit KHK. Z Kardiol 77:179PubMedGoogle Scholar
  127. 127.
    Laks MN (1976) Norepinephrine — The myocardial hypertrophy hormone? Am Heart J 91:674PubMedCrossRefGoogle Scholar
  128. 128.
    Laufer E, Jennings GL, Korner PI, Dewas E (1989) Prevalence of cardiac structural and functional abnormalities in untreated primary hypertension. Hypertension 13:151PubMedGoogle Scholar
  129. 129.
    Leenen FH, Smith DL, Farkas RM, Reevers R, Marquez-Julio A (1987) Vasodilators and regression of left ventricular hypertrophy: hydralazine versus prazosin in hypertensive humans. Am J Med 82:969PubMedCrossRefGoogle Scholar
  130. 130.
    Lehmann M, Dickhut H-H, Dürr H, Keul J (1989) Regression der hypertoniebedingten Linksherzhypertrophie bei Sportlern. Dtsch Z Sportmed 5:177Google Scholar
  131. 131.
    Leschke M, Martin J, Vogt M, Motz W, Strauer BE (1990) Die Blutviskosität: ein additiver Faktor der eingeschränkten Koronarreserve bei der arteriellen Hypertonie. Z Kardiol 79:101Google Scholar
  132. 132.
    Levy D, Anderson K, Savage P, Balkus S, Kannel WB, Castelli WP (1987) Risk of left ventricular arrhythmias in left ventricular hypertrophy. The Framingham Heart Study. Am J Cardiol 60:560PubMedCrossRefGoogle Scholar
  133. 133.
    Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP (1988) Echocardiographically detected left ventricular hypertrophy: prevalence and risk factor. Ann Intern Med 1089:7Google Scholar
  134. 134.
    Levy D (1988) Left ventricular hypertrophy. Epidemiological insights from the Framingham Heart Study. Drugs (Suppl 5):1CrossRefGoogle Scholar
  135. 135.
    Levy D, Garrison RJ, Savage DD, Kannel W, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. New Engl J Med 322:1561PubMedCrossRefGoogle Scholar
  136. 136.
    Levy B, Michel JB, Salzmann JL, Azizi M, Poitevin P, Safar M, Camilleri JP (1988) Effect of chronic inhibition of converting enzyme on mechanical and structure properties of arteries in rat renovascular hypertension. Circ Res 63:227PubMedGoogle Scholar
  137. 137.
    Limas CJ, Cohn JN (1977) Defective calcium transport bei cardiac sarcoplasmic reticulum in spontaneously hypertensive rats. Circ Res (Suppl 1)40:62Google Scholar
  138. 138.
    Limas CJ, Spier SS (1980) Effect of antihypertensive therapy on calcium transport by cardiac sarcoplasmic reticulum of SHRs. Cardiovasc Res 14:692PubMedCrossRefGoogle Scholar
  139. 139.
    Linzbach AJ (1960) Heart failure from the point of view of quantitative anatomy. Am J Cardiol 5:370PubMedCrossRefGoogle Scholar
  140. 140.
    Litten RZ, Martin BJ, Low RB, Alpert NR (1982) Altered myosin isozyme patterns from pressure-overloaded and thyrotoxic hypertrophied rabbit hearts. Circ Res 50:856PubMedGoogle Scholar
  141. 141.
    Little WC, Downes TR (1990) Clinical evaluation of left ventricular diastolic performance. Prog Cardiovasc Dis XXXII:273CrossRefGoogle Scholar
  142. 142.
    Löllgen H, Ulmer H-V, Crean P (1988) Recommendations and standard guidelines for exercise testing. Europ Heart J 9 (Suppl 4):3Google Scholar
  143. 143.
    Long CS, Simpson PC (in print) Sympathetic activity modulation of cardiac hypertrophy. J Cardiovasc PharmacolGoogle Scholar
  144. 144.
    Lüscher TF, Vanhoutte PM, Raij L (1987) Antihypertensive treatment normalizes decreased endotheliumdependant relaxations in rats with salt-induced hypertension. Hypertension 9 (Suppl III): 193Google Scholar
  145. 145.
    Lund-Johansen P (1967) Hemodynamics in early essential hypertension. Acta Med Scand 183 (Suppl 482):1Google Scholar
  146. 146.
    Lundin SA, Halback-Nordlander MIL (1984) Regression of structural cardiovascular changes by antihypertensive therapy in spontaneously hypertensive rats. Hypertension 2:11CrossRefGoogle Scholar
  147. 147.
    Mahoney LT, Schieken R, Clarke W, Lauer R (1988) Left ventricular mass and exercise responses predict future blood pressure. The Muscatine Study. Hypertension 12:206PubMedGoogle Scholar
  148. 148.
    Marcus ML, Doty DB, Hiratzka LF, Wright CB, Eastham C (1982) Decreased coronary reserve: a mechanism for angina pectoris and normal coronary arteries. New Engl J Med 307:1362PubMedCrossRefGoogle Scholar
  149. 149.
    McFarland TM, Mohsin A, Goldstein S, Pickard SD, Stein PD (1978) Echocardiographic diagnosis of left ventricular hypertrophy. Circulation 57:1140PubMedGoogle Scholar
  150. 150.
    McLenachan JM, Henderson E, Morris K, Dargie H (1987) Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. New Engl J Med 317:787PubMedCrossRefGoogle Scholar
  151. 151.
    McLenachan JM, Dargie HH (in print) Determinants of ventricular arrhythmias in left ventricular hypertrophy. J Cardiovasc PharmacolGoogle Scholar
  152. 152.
    Messerli FH, Schmieder RE (1990) Arterielle Hypertonie, linksventrikuläre Hypertrophie und plötzlicher Herztod. Dtsch Med Wochenschr 115:1682PubMedCrossRefGoogle Scholar
  153. 153.
    Messerli FH, Ventura HO, Glade LB, Sundgaard-Rüse K, Dunn FG, Frohlich ED (1983) Essential hypertension in the elderly. Haemodynamics, intravascular volume, plasma renin activity and circulating catecholamine levels. Lancet 11:983CrossRefGoogle Scholar
  154. 154.
    Messerli FH, Ventura HO, Dunn FG, Frohlich EO (1984) Hypertension and sudden death. Am J Med 77:18PubMedCrossRefGoogle Scholar
  155. 155.
    Messerli FH, Nunez BD, Nunez M, Garavaglia G, Schmieder RE, Ventura HO (1989) Hypertension and sudden death. Disparate effects of calcium entry blocker and diuretic therapy on cardiac dysrhythmias. Arch Intern Med 149:1263PubMedCrossRefGoogle Scholar
  156. 156.
    Meyer-Sabellek W, Ketelhut R, Franz I-W, Schulte K, Gotzen R (1984) 24-Stunden-Blutdrucktagesprofil und Fahrradergometrie in der Beurteilung der sogenannten milden Hypertonic Therapiewoche 34:6417Google Scholar
  157. 157.
    Michel JA, Salzmann JL, De Lourdes Carol M, Dussaule JC, Azzi M, Lorman B, Camillerie JP, Corvol P (1988) Myocardial effects of converting enzyme inhibition in hypertensive and normotensive rats. Am J Med (Suppl 3A):12CrossRefGoogle Scholar
  158. 158.
    Miller IT, O’Rourke R, Crawford M (1988) Left arterial enlargement: an early sign of hypertensive heart disease. Am Heart J 116:1048PubMedCrossRefGoogle Scholar
  159. 159.
    Molineux P, Steptoe A (1987) Exaggerated blood pressure responses to submaximal exercise in normotensive adolescents with a family history of hypertension. J Hypertension 6:361Google Scholar
  160. 160.
    Morganroth J, Maron B, Henry W, Epstein S (1975) Comparative left ventricular dimensions in trained athletes. Ann Intern Med 82:521PubMedGoogle Scholar
  161. 161.
    Motz W, Strauer BE (1988) Rückbildung der hypertensiven Herzhypertrophie durch chronische Angiotensin-Konversionsenzymhemmung. Z Kardiol 77:53PubMedGoogle Scholar
  162. 162.
    Motz W, Strauer BE (1989) Left ventricular function and collagen content after regression of hypertensive hypertrophy. Hypertension 13:43PubMedGoogle Scholar
  163. 163.
    Motz W, Vogt M, Schwartzkopff B, Strauer BE (in print) Regulation of coronary circulation in hypertensive hypertrophy. J Cardiovasc PharmacolGoogle Scholar
  164. 164.
    MRC Trial of treatment of mild hypertension: principal results (1985) Medical Research Council Working Party. Br Med J 291:97Google Scholar
  165. 165.
    Muiesan G, Agabiti-Rosei E, Romanelli G, Muiesan ML, Castellano M, Beschi M (1986) Adrenergic activity and left ventricular function during treatment of essential hypertension with calcium antagonists. Am J Cardiol 57:44CrossRefGoogle Scholar
  166. 166.
    Muiesan ML, Agabiti-Rosei E, Romanelli G, Beschi M, Castellano M, Alani G, Muiesan G (1989) Redevelopment of hypertension after treatment withdrawal and regression of cardiac hypertrophy. Consequences on left ventricular function and plasma catecholamines. Circulation 80 (Suppl II):596Google Scholar
  167. 167.
    Mulvany MJ, Korsgaard N (1983) Correlations and otherwise between blood pressure, cardiac mass and resistance vessel characteristics in hypertensive, normotensive and hypertensive/normotensive hybrid rats. Hypertension 1:235CrossRefGoogle Scholar
  168. 168.
    Muscholl M, Dennig K, Kraus F, Rudolph W (1990) Echokardiographische und dopplerechokardiographische Charakterisierung der linksventrikulären diastolischen Funktion. Herz 15:377PubMedGoogle Scholar
  169. 169.
    Nakashima J, Bouad F, Tarazi R (1984) Regression of left ventricular hypertrophy from systemic hypertension by enalapril. Am J Cardiol 53:1044PubMedCrossRefGoogle Scholar
  170. 170.
    Nathwani D, Reevers RA, Marquez-Julio A (1985) Left ventricular hypertrophy in mild hypertension. Correlation with exercise blood pressure. Am Heart J 109:386PubMedCrossRefGoogle Scholar
  171. 171.
    Nava-Lopez G, Monteverde C, Jauregui R, del Rio A, Velez M, Ponce L, de la Clata M (1989) X-syndrome. Angiographic findings. Arch Inst Cardiol Mex 59:257PubMedGoogle Scholar
  172. 172.
    Neyses L, Williams RS, Sukhatme VP, Vetter H (1990) Direkte Wirkung des Angiotensin II auf Genexpression im Myokard-Hinweis auf Hypertrophieinduktion durch AII. Z Kardiol 79:80Google Scholar
  173. 173.
    Nunberger D, Robert M, Hochrein H (1990) Antihypertensive Behandlung stummer Myokardischämien bei Hypertonikern ohne koronare Herzkrankheit. Dtsch Med Wochenschr 115:969PubMedCrossRefGoogle Scholar
  174. 174.
    Opherk D, Mall G, Zebe H, Schwarz F, Weihe E, Manthey J, Kübler W (1984) Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation 69:1PubMedCrossRefGoogle Scholar
  175. 175.
    Otterstadt JE, Knutsen K, Michelsen S, Stugaard M, Froeland G, Wasenins A (1989) Is left ventricular mass in apparently healthy normotensive men correlated to maximal blood pressure during a symptom-limited exercise test. Fourth European Meeting on Hypertension, Milan, Abstract 637Google Scholar
  176. 176.
    Patyna WD (1984) Die prognostische Bedeutung des Belastungsblutdrucks für die Hypertonieentstehung bei Koronarkranken. Herz/Kreisl 12:627Google Scholar
  177. 177.
    Paulsen S, Vetner M, Hagerup LM (1975) Relationship between heart weight and the cross-sectional area of the coronary ostia. Acta Pathol Microbiol Scand 83:429Google Scholar
  178. 178.
    Paulsen W, Derek R, Bonghner R, Ko P, Cunningham DA, Persand JA (1981) Left ventricular function in marathon runners: echocardiographic assessment. J Appl Physiol 51:881PubMedGoogle Scholar
  179. 179.
    Pearson AC, Labovitz AJ, Mrosek D, Williams GA, Kennedy HL (1987) Assessment of diastolic function in normal and hypertrophied hearts: comparison of doppler echocardiography and m-mode echocardiography. Am Heart J 113:1417PubMedCrossRefGoogle Scholar
  180. 180.
    Pelliccia A, Spataro A, Granata M, Biffi A, Caselli G, Alabiso A (1990) Coronary arteries in physiological hypertrophy: echocardiographic evidence of increased proximal size in elite athletes. Int J Sports Med 11:120PubMedCrossRefGoogle Scholar
  181. 181.
    Perloff D, Sokolow M, Cowan R (1983) The prognostic value of ambulatory blood pressures. JAMA 249:2792PubMedCrossRefGoogle Scholar
  182. 182.
    Pfeffer MA, Frohlich ED (1973) Hemodynamic and myocardial function in young and old normotensive and spontaneously hypertensive rats. Circ Res 32/33 (Suppll):28PubMedGoogle Scholar
  183. 183.
    Phillips RA, Goldman ME, Ardeljan M, Arora R, Eison HB, Yu BY, Krakoff LR (1989) Determinants of abnormal left ventricular filling in early hypertension. J Am Coll Cardiol 14:979PubMedCrossRefGoogle Scholar
  184. 184.
    Picca M, Azzolini F, Zocca A, Bisleglia J, Pelosi G (1989) Effects of long-term enalapril therapy on left ventricular hypertrophy and systolic function in essential hypertension. Fourth European Meeting on Hypertension; Milan, Abstract 682Google Scholar
  185. 185.
    Pringle SD, Mac Farlane PW, Mc Killop JH, Lorimer AR, Dunn FG (1989) Pathophysiologic assessment of left ventricular hypertrophy and strain in asymptomatic patients with essential hypertension. J Am Coll Cardiol 13:377CrossRefGoogle Scholar
  186. 186.
    Radice M, Alli C, Avanzini F (1986) Left ventricular structure and function in normotensive adolescents with a genetic predisposition to hypertension. Am Heart J 111:115PubMedCrossRefGoogle Scholar
  187. 187.
    Reichek N, Helok J, Plappert T (1983) Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography. Initial results. Circulation 67:348PubMedCrossRefGoogle Scholar
  188. 188.
    Reiner L, Mazzoleni A, Rodriguez FL, Freudenthal RR (1959) The weight of the human heart. I. “Normal” cases. AMA Arch Path 68:58Google Scholar
  189. 189.
    Ren J, Hakki A, Kotler MN (1985) Exercise systolic blood pressure: A powerful determinant of increased left ventricular mass in patients with hypertension. J Am Coll Cardiol 5:1224PubMedCrossRefGoogle Scholar
  190. 190.
    Roberts WC (1975) The hypertensive diseases. Evidence that systemic hypertension is a greater risk factor to the development of other cardiovascular disease than previously suspected. Am J Med 59:523PubMedCrossRefGoogle Scholar
  191. 191.
    Rokey R, Kuo LC, Zoghbi WA, Limacher M, Quinones MA (1985) Determination of parameters of left ventricular diastolic filling with pulsed doppler echocardiography: comparison with cineangiography. Circulation 71:543PubMedCrossRefGoogle Scholar
  192. 192.
    Rost R (im Druck) Herz und Sport. Dtsch Ärzteverlag, KölnGoogle Scholar
  193. 193.
    Rowlands DB, Ireland MA, Stallard T, Clover D, McLeay R, Watson R, Littler W (1982) Assessment of left ventricular mass and its response to antihypertensive treatment. Lancet 1:467PubMedCrossRefGoogle Scholar
  194. 194.
    Safar ME (in print) Regression of cardiac hypertrophy and arterial compliance in hypertension. J Cardiovasc PharmacolGoogle Scholar
  195. 195.
    Sahn DJ, de Maria A, Kisslo J, Weymann A (1977) The Committee on m-mode standardization of the American Society of Echocardiography. Recommendations regarding quantification in m-mode echocardiography. Results of a survey of echocardiographic measurements. Circulation 58:1072Google Scholar
  196. 196.
    Sannerstedt R (1969) Hemodynamic finding at rest and during exercise in mild hypertension. Am J Med Sci 258:70PubMedCrossRefGoogle Scholar
  197. 197.
    Sau F, Cherchi A, Seguro C (1982) Reversal of left ventricular hypertrophy after treatment of hypertension by atenolol for one year. Clin Sci 63 (Suppl 8):367Google Scholar
  198. 198.
    Savage DD, Drayer JI, Henry WL, Mathews EC, Ware JH, Gardin JM, Cohen ER, Epstein SE, Laragh JH (1979) Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects. Circulation 59:623PubMedGoogle Scholar
  199. 199.
    Savage DD, Garrison RJ, Kannel WB, Levy D, Anderson SJ, Strokes J, Feinleib M, Castelli WP (1987) The spectrum of left ventricular hypertrophy in a general population sample: The Framingham Study. Circulation 75 (Suppl I):26Google Scholar
  200. 200.
    Scharf RE, Schneider W (1984) Die Rolle der Blutplättchen bei Mikrozirkula-tionsstörungen. Dtsch Med Wochenschr 109:306PubMedCrossRefGoogle Scholar
  201. 201.
    Schlant RC, Feiner JM, Heymsfield SG (1977) Echocardiographic studies of left ventricular anatomy and function in essential hypertension. Cardiovasc Med 2:477Google Scholar
  202. 202.
    Schlant RC, Feiner JM, Blumenstein BA, Wollam GL, Hall WA, Schulmann NB, Heymsfield SB, Gilbert CA, Tuttle EP (1982) Echocardiographic documentation of regression of left ventricular hypertrophy in patients treated for essential hypertension. Europ Heart J 3 (Suppl A):171Google Scholar
  203. 203.
    Scheler S, Motz W, Strauer BE (1989) Transiente Myokardischämie bei Hypertonikern. Z Kardiol 78:197PubMedGoogle Scholar
  204. 204.
    Scheler S, Vogt M, Motz W, Strauer BE (1990) Transiente myokardiale Ischämien bei hypertensiver Mikroangiopathie. Z Kardiol 79 (Suppl I):80Google Scholar
  205. 205.
    Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD (1987) Cardiovascular effects of verapamil in patients with essential hypertension. Circulation 175:1030CrossRefGoogle Scholar
  206. 206.
    Schmieder RE, Messerli FH, Sturgill D, Garavaglia G, Nunez B (1989) Cardiac performance after reduction of myocardial hypertrophy. Am J Med 87:22PubMedCrossRefGoogle Scholar
  207. 207.
    Schulman SP, Weiss JL, Becker LC, Gottlieb SO, Woodruff KM, Weisfeldt ML, Gerstenblith G (1990) The effects of antihypertensive therapy on left ventricular mass in elderly patients. New Engl J Med 322:1350PubMedCrossRefGoogle Scholar
  208. 208.
    Schwarz F, Flameng W, Schaper J, Langebartels F, Gesto M, Hehrlein F, Schlepper M (1978) Myocardial structure and function in patients with aortic valve disease and their relation to postoperative results. Am J Cardiol 41:661PubMedCrossRefGoogle Scholar
  209. 209.
    Schwarzkopff B, Daubel A, Frenzel H, Rettig B, Vogelsang H, Hort W (1990) Induktion und Reversibilität struktureller Veränderungen der intramuralen Herzarterien. Z Kardiol 79:107Google Scholar
  210. 210.
    Sen S, Tarazi RG, Khairrallah PA, Bumpus FM (1974) Cardiac hypertrophy in spontaneously hypertensive rats. Circulation Res 35:775PubMedGoogle Scholar
  211. 211.
    Sen S, Tarazi RC, Bumper FM (1976) Biochemical changes associated with development and reversal of cardiac hypertrophy in spontaneously hypertensive rats. Cardiovasc Res 10:254PubMedCrossRefGoogle Scholar
  212. 212.
    Sen S, Tarazi RC, Bumper FM (1979) Cardiac effects of angiotensin-antagonists in normotensive rats. Clin Sci 56:439PubMedGoogle Scholar
  213. 213.
    Sen S, Petscher C, Ratliff N (1987) A factor that initiates myocardial hypertrophy in hypertension. Hypertension 9:261PubMedGoogle Scholar
  214. 214.
    Shahi M, Thorn M, Poulter N, Sever PS, Foale RA (1990) Regression of hypertensive left ventricular hypertrophy and left ventricular diastolic function. Lancet 336:458PubMedCrossRefGoogle Scholar
  215. 215.
    Shapiro LM, McKenna WJ (1984) Left ventricular hypertrophy. Relation of structure to diastolic function in hypertension. Br Heart J 51:637PubMedCrossRefGoogle Scholar
  216. 216.
    Siegrist J, Matschinger H, Motz W (1987) Untreated hypertensives and their quality of life. J Hypert 5 (Suppl 1):15Google Scholar
  217. 217.
    Simpson P (1983) Norepinephrine-stimulated hypertrophy of cultured rat myocardial cell is a alpha-1 adrenergic response. J Clin Invest 72:732PubMedCrossRefGoogle Scholar
  218. 218.
    Smith VE, Schulmann P, Karimeddini MK, White WB, Meeran MK, Katz AM (1985) Rapid ventricular filling in left ventricular hypertrophy: II. pathologic hypertrophy. J Am Coll Cardiol 5:869PubMedCrossRefGoogle Scholar
  219. 219.
    Smith VE, White WB, Meeran MK, Karimeddini MK (1986) Improved left ventricular filling accompanies reduced left ventricular mass during therapy of essential hypertension. J Am Coll Cardiol 8:1449PubMedCrossRefGoogle Scholar
  220. 220.
    Stein RA, Michielli D, Diamond J, Horwitz B, Krasnow N (1980) The cardiac response to exercise training: echocardiographic analysis at rest and during exercise. Am J Cardiol 46:219PubMedCrossRefGoogle Scholar
  221. 221.
    Störk T, Müller R, Ewert C, Piske G, Wienhold S, Hochrein H (1990) Wirkung von Nikotin auf die linksventrikuläre diastolische Funktion bei koronarkranken Patienten. Dtsch Med Wochenschr 115:610PubMedCrossRefGoogle Scholar
  222. 222.
    Strandgaard S (1976) Autoregulation of cerebral blood flow in hypertensive patients: the modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-influenced hypertension. Circulation 53:720PubMedGoogle Scholar
  223. 223.
    Strauer BE (1979) Das Hochdruckherz. Springer, Berlin Heidelberg New YorkGoogle Scholar
  224. 224.
    Strauer BE, Motz W (1988) Hypertonie und Herz. Internist 19:260Google Scholar
  225. 225.
    Strauer BE, Motz W, Vogt M (1989) Therapie der myokardialen und koronaren Auswirkungen des arteriellen Bluthochdrucks. Z Kardiol 78 (Suppl 1):128Google Scholar
  226. 226.
    Svanegaard J, Angelo-Nielsen K, Schultz Hansen J (1989) Physiological hypertrophy of the heart and atrial natriuretic peptide during rest and exercise. Br Heart J 62:445PubMedCrossRefGoogle Scholar
  227. 227.
    Tarazi RC, Sen S, Fouad FM, Wicker R (1983) Regression of myocard hypertrophy. Conditions and sequelae of reversal in hypertensive heart disease. In: Alpert NR (ed) Perspectives in cardiovascular research, vol 7, Myocardial hypertrophy and failure. Raven Press, New York, p 637Google Scholar
  228. 228.
    Tarazi RC, Fouad FM (1984) Reversal of cardiac hypertrophy in humans. Hypertension 6:141Google Scholar
  229. 229.
    Tarazi RC, Frohlich ED (1987) Is reversal of cardiac hypertrophy a desirable goal of antihypertensive therapy? Circulation 5 (Suppl I):113Google Scholar
  230. 230.
    Tauchert M, Jansen W (1990) Pulmonary arterial pressure and working capacity as parameters for checking the development of tolerance under nitrate therapy. Z Kardiol 79 (Suppl 3):67PubMedGoogle Scholar
  231. 231.
    The Australian therapeutic trial in mild hypertension. Report by the Management Committee. Lancet 1:1261Google Scholar
  232. 232.
    The Multiple Risk Factor Intervention Trial Research Group (1990) Mortality rates after 10.5 years for participants in the MRFIT Trial. JAMA 263:1795CrossRefGoogle Scholar
  233. 233.
    Tillmanns H, Neumann F-J, Mattfeld T, Mall G, Waas W, Steinhausen M (1990) Veränderungen der myokardialen Mikrozirkulation bei druckinduzierter linksventrikulärer Hypertrophie. Z Kardiol 79 (Suppl I):58Google Scholar
  234. 234.
    Tomanek RJ, Palmer PJ, Pieffer GW, Schrieber K, Eastham CL, Marcus ML (1986) Morphometry of canine coronary arteries, artenoles and capillaries during hypertension and left ventricular hypertrophy. Circ Res 58:38PubMedGoogle Scholar
  235. 235.
    Trimarco B, Wikstrand J (1984) Regression of cardiovascular structural changes by antihypertensive treatment. Hypertension 6 (Suppl III):150Google Scholar
  236. 236.
    Trimarco B, De Luca N, Ricciarelli B (1988) Cardiac function in systemic hypertension before and after reversal of left ventricular hypertrophy. Am J Cardiol 62:745PubMedCrossRefGoogle Scholar
  237. 237.
    Topol EJ, Traill TA, Fortuin NJ (1985) Hypertensive hypertrophic cardiomyopathy of the elderly. New Engl J Med 312:277PubMedCrossRefGoogle Scholar
  238. 238.
    Troy BI, Pombo G, Racklev CE (1972) Measurement of left ventricular wall thickness and mass by echocardiography. Circulation 15:602Google Scholar
  239. 239.
    Umali MSA, Prakash R (1984) Magnitude of daily variations in serial echocar-diographic measurements of septal thickness, left ventricular wall thickness and estimated left ventricular mass. Clin Res 32:212Google Scholar
  240. 240.
    Urhausen A, Kindermann W (1990) Echokardiographische Befunde bei Bodybuildern im Vergleich zu Hochausdauertrainierten. Dtsch Z Sportmed 41:12Google Scholar
  241. 241.
    Ventura HO, Frohlich ED, Messerli FH, Kobrin I, Kardon MB (1985) Cardiovascular effects and regional blood flow distribution associated with angiotensin converting enzyme inhibition (Captopril) in essential hypertension. Am J Cardiol 55:1023PubMedCrossRefGoogle Scholar
  242. 242.
    Vogt M, Kreutz KU, Motz W, Strauer BE (1988) Verbesserung der diastolischen Funktion durch Regression der linksventrikulären Hypertrophie. Z Kardiol (Suppl 1):580Google Scholar
  243. 243.
    Vogt M, Mildenberger E, Rabenau O, Lückhoff A, Motz W, Strauer BE (1990) Hinweis für das Vorliegen einer Endotheldysfunktion bei Patienten mit Angina pectoris und unauffälligem Koronarangiogramm. Z Kardiol 79 (Suppl I):61Google Scholar
  244. 244.
    Vogt M, Scheler S, Motz W, Strauer BE (1990) Ventrikuläre Herzrhythmusstörungen bei Hypertonikern. Z Kardiol 79:103Google Scholar
  245. 245.
    Wallrabe D, Schäfer RO, Heine H, Menz M (1989) Kombinierte Doppler- und M-mode echokardiographische Analyse des ventrikulären Füllungsverhaltens bei linksventrikulärer Hypertrophie verschiedener Genese. Cor Vas 1:33Google Scholar
  246. 246.
    Weber JR (1988) Left ventricular hypertrophy: its prime importance as a controllable risk factor. Am Heart J 116:272PubMedCrossRefGoogle Scholar
  247. 247.
    Weber KT, Brilla CG, Janicki JS (in print) Signals for the remodeling of the cardiac interstitium in systemic hypertension. J Cardiovasc PharmacolGoogle Scholar
  248. 248.
    White WB, Schulman P, Karimeddini MK (1989) Regression of left ventricular mass is accompanied by improvement in rapid left ventricular filling following antihypertensive therapy with metoprolol. Am Heart J 117:145PubMedCrossRefGoogle Scholar
  249. 249.
    White WB, Schulmann P, McCabe J, Dey H (1989) Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA 261:873PubMedCrossRefGoogle Scholar
  250. 250.
    White WB, Holley M, Dey M, Schulman P (1989) Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild-to-moderate hypertension. Am Heart J 118:782PubMedCrossRefGoogle Scholar
  251. 251.
    Wicker P, Tarazi RC, Kobayashi K (1983) Coronary blood flow with reversal of cardiac hypertrophy. Am J Cardiol 51:1744PubMedCrossRefGoogle Scholar
  252. 252.
    Wiechmann HW (1990) Ruhe- und Belastungshämodynamik bei essentieller Hypertonie. Dtsch Med Wochenschr 115:163PubMedCrossRefGoogle Scholar
  253. 253.
    Wikstrand JI, Warnold, Olson G, Tuomiletho JD, Elmfeldt D, Berglund G (1988) Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPYH-Study. JAMA 259:1976PubMedCrossRefGoogle Scholar
  254. 254.
    Wilson MF, Sung BH, Pincomb GA, Covallo WR (1990) Exaggerated pressure response to exercise in men at risk for systemic hypertension. Am J Cardiol 66:731PubMedCrossRefGoogle Scholar
  255. 255.
    Wollam GL, Hall WD, Porter VD, Douglas MB, Unger D, Blumenstein BA, Cotson’s GA, Knudtson ML, Feiner JM, Schlant RC (1983) Time course of regression of left ventricular hypertrophy in treated hypertensive patients. Am J Med 75 (Suppl 3A):100PubMedCrossRefGoogle Scholar
  256. 256.
    Wong HO, Kasser JS, Bruce R (1969) Impaired maximal exercise performance with hypertensive cardiovascular disease. Circulation XXXIX: 633Google Scholar
  257. 257.
    Yamori Y, Igawa T, Tagami M, Kaube T, Nara Y, Kihera M, Horie R (1984) Humoral trophic influence on cardiovascular structural changes in hypertension. Hypertension 6 (Suppl III): 27Google Scholar
  258. 258.
    Zahka KG (1986) Risk of cardiac involvement in essential hypertension. Cardiol Clin 4:81PubMedGoogle Scholar
  259. 259.
    Zanna F, Voisin P, Brunotte F (1988) Haemorheological abnormalities in arterial hypertension and their relation to cardiac hypertrophy. J Hypertens 6:293Google Scholar
  260. 260.
    Zähringer J, Stangl-Danninger B, Aschawer W, Motz W, Strauer BE (1985) Regression of heart muscle hypertrophy after nifedipine therapy: changes in cardiac gene expression. J Hypertension 3 (Suppl 3):493Google Scholar
  261. 261.
    Zähringer J (1985) Biochemische Veränderungen bei Herzmuskelhypertrophieregression. Z Kardiol 74 (Suppl 7):119PubMedGoogle Scholar
  262. 262.
    Zeiher AM, Drexler H, Wollschlaeger H, Saurbier B, Just H (1989) Coronary vasomotion in response to sympathetic Stimulation in humans: Importance of the functional integrity of the endothelium. J Am Coll Cardiol 14:1181PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • Ingomar-Werner Franz
    • 1
  1. 1.Klinik Wehrawald der BfARehabilitationszentrum für Herz-, Kreislauf- und LungenerkrankungenTodtmoos/SchwarzwaldDeutschland

Personalised recommendations